3 Result(s)

Article

Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer

Current data suggest that platinum-based combination therapy is the standard first-line treatment for biliary tract cancer. EGFR inhibition has proven beneficial across a number of gastrointestinal malignancie...

A F Hezel, M S Noel, J N Allen, T A Abrams, M Yurgelun… in British Journal of Cancer (2014)

Article

Sunitinib in combination with gemcitabine for advanced solid tumours: a phase I dose-finding study

This phase I, dose-finding study determined the maximum tolerated dose (MTD), safety, and pharmacokinetics of sunitinib plus gemcitabine in patients with advanced solid tumours.

M D Michaelson, A X Zhu, D P Ryan, D F McDermott, G I Shapiro… in British Journal of Cancer (2013)

Article

Oxaliplatin-induced Evan’s syndrome

C C Earle, W Y Chen, D P Ryan, R J Mayer in British Journal of Cancer (2001)